美国13家私立诊所成人疫苗接种盈利性分析
本研究于2017年在美国九个州招募19家诊所,对其中13家具有完整成本与支付数据的诊所进行时间-动作研究和管理者调查,比较成人疫苗接种的成本与支付。结果显示疫苗接种服务年收入中位数在家庭医学诊所、内科诊所和妇产科诊所分别为90,343美元、28,267美元和2,886美元,整体中位数盈利但各诊所差异大。
要点
- 成人疫苗接种服务整体中位数盈利,但诊所间差异大。
- 家庭医学诊所年收入中位数90,343美元,内科28,267美元,妇产科2,886美元。
- 成本与支付率差异是盈利性变异的主要来源。
核心结论
- 成人疫苗接种在本样本中位数水平上盈利,但因成本和支付率差异导致盈利性变异很大。
研究设计与样本
- 2017年在美国九个州招募19家诊所的便利样本,对其中13家具有完整成本与支付数据的诊所进行时间-动作研究和管理者调查。
主要发现
- 家庭医学诊所疫苗接种服务年收入中位数为90,343美元(范围:3,968–249,628美元)。
- 内科诊所疫苗接种服务年收入中位数为28,267美元(范围:-32,659–141,034美元)。
- 妇产科诊所疫苗接种服务年收入中位数为2,886美元(范围:-73,451–23,820美元)。
临床怎么用
- 诊所在决定是否提供成人疫苗时可参考本研究的成本与支付比较结果。
- 改善财务可行性可能有助于提高成人疫苗接种覆盖率。
局限性
- 仅13家诊所提供完整成本与支付数据,样本量小。
- 采用便利样本,可能不代表全美诊所情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccination coverage among adults remains low in the United States. Understanding the barriers to provision of adult vaccination is an important step to increasing vaccination coverage and improving public health. To better understand financial factors that may affect practice decisions about adult vaccination, this study sought to understand how costs compared with payments for adult vaccinations in a sample of U.S. physician practices. We recruited a convenience sample of 19 practices in nine states in 2017. We conducted a time-motion study to assess the time costs of vaccination activities and conducted a survey of practice managers to assess materials, management, and dose costs and payments for vaccination. We received complete cost and payment data from 13 of the 19 practices. We calculated annual income from vaccination services by comparing estimated costs with payments received for vaccine doses and vaccine administration. Median annual total income from vaccination services was $90,343 at family medicine practices (range: $3968-$249,628), $28,267 at internal medicine practices (-$32,659-$141,034) and $2886 at obstetrics and gynecology practices (-$73,451-$23,820). Adult vaccination was profitable at the median of our sample, but there is wide variation in profitability due to differences in costs and payment rates across practices. This study provides evidence on the financial viability of adult vaccination and supports actions for improving financial viability. These results can help inform practices' decisions whether to provide adult vaccines and contribute to keeping adults up-to-date with the recommended vaccination schedule.
引用
- Yarnoff B, Khavjou O, King G, et al. Analysis of the profitability of adult vaccination in 13 private provider practices in the United States. Vaccine. 2019. PMID: 31495594. doi:10.1016/j.vaccine.2019.08.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。